KR20190100205A - 당뇨성 말초 신경병증 치료용 물품 - Google Patents
당뇨성 말초 신경병증 치료용 물품 Download PDFInfo
- Publication number
- KR20190100205A KR20190100205A KR1020197018171A KR20197018171A KR20190100205A KR 20190100205 A KR20190100205 A KR 20190100205A KR 1020197018171 A KR1020197018171 A KR 1020197018171A KR 20197018171 A KR20197018171 A KR 20197018171A KR 20190100205 A KR20190100205 A KR 20190100205A
- Authority
- KR
- South Korea
- Prior art keywords
- article
- peripheral neuropathy
- tissue
- target
- electrical stimulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000032131 Diabetic Neuropathies Diseases 0.000 title claims description 30
- 230000000638 stimulation Effects 0.000 claims abstract description 98
- 210000001519 tissue Anatomy 0.000 claims abstract description 63
- 238000000034 method Methods 0.000 claims abstract description 54
- 210000000944 nerve tissue Anatomy 0.000 claims abstract description 52
- 208000033808 peripheral neuropathy Diseases 0.000 claims abstract description 47
- 230000002792 vascular Effects 0.000 claims abstract description 34
- 230000001537 neural effect Effects 0.000 claims abstract description 21
- 230000024883 vasodilation Effects 0.000 claims abstract description 16
- 208000002193 Pain Diseases 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 22
- 210000004204 blood vessel Anatomy 0.000 claims description 11
- 230000005684 electric field Effects 0.000 claims description 11
- 210000000578 peripheral nerve Anatomy 0.000 claims description 11
- 206010040030 Sensory loss Diseases 0.000 claims description 9
- 210000005036 nerve Anatomy 0.000 claims description 8
- 210000005166 vasculature Anatomy 0.000 claims description 8
- 230000010412 perfusion Effects 0.000 claims description 5
- 239000012778 molding material Substances 0.000 claims description 4
- 238000011084 recovery Methods 0.000 claims description 3
- 210000002683 foot Anatomy 0.000 description 23
- 210000003371 toe Anatomy 0.000 description 20
- 239000012530 fluid Substances 0.000 description 13
- 230000017531 blood circulation Effects 0.000 description 11
- 206010012601 diabetes mellitus Diseases 0.000 description 11
- 239000004744 fabric Substances 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 210000001367 artery Anatomy 0.000 description 6
- 230000008081 blood perfusion Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 208000035824 paresthesia Diseases 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 239000004020 conductor Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 229920002120 photoresistant polymer Polymers 0.000 description 4
- 208000000094 Chronic Pain Diseases 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 238000005229 chemical vapour deposition Methods 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 2
- 102000004414 Calcitonin Gene-Related Peptide Human genes 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010049567 Miller Fisher syndrome Diseases 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 241000220010 Rhode Species 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 208000003295 carpal tunnel syndrome Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- -1 etc.) Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000000976 ink Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000007383 nerve stimulation Effects 0.000 description 2
- 201000001119 neuropathy Diseases 0.000 description 2
- 230000007823 neuropathy Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000004544 sputter deposition Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 239000003039 volatile agent Substances 0.000 description 2
- 208000003808 Amyloid Neuropathies Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010068597 Bulbospinal muscular atrophy congenital Diseases 0.000 description 1
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical class C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000017899 Foot injury Diseases 0.000 description 1
- 208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
- 208000011092 Hand injury Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000027747 Kennedy disease Diseases 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 206010029174 Nerve compression Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 208000001163 Tangier disease Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 208000007642 Vitamin B Deficiency Diseases 0.000 description 1
- 206010047627 Vitamin deficiencies Diseases 0.000 description 1
- 208000006269 X-Linked Bulbo-Spinal Atrophy Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000012984 antibiotic solution Substances 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 239000005441 aurora Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000005465 channeling Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000013481 data capture Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008482 dysregulation Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002357 endometrial effect Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 229910003472 fullerene Inorganic materials 0.000 description 1
- 229910021397 glassy carbon Inorganic materials 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000037427 ion transport Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008720 membrane thickening Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 210000001872 metatarsal bone Anatomy 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 229910021392 nanocarbon Inorganic materials 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 230000006764 neuronal dysfunction Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000012811 non-conductive material Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229940005483 opioid analgesics Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 208000027232 peripheral nervous system disease Diseases 0.000 description 1
- 238000005240 physical vapour deposition Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920005596 polymer binder Polymers 0.000 description 1
- 239000002491 polymer binding agent Substances 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 238000005546 reactive sputtering Methods 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 210000002265 sensory receptor cell Anatomy 0.000 description 1
- 102000027509 sensory receptors Human genes 0.000 description 1
- 108091008691 sensory receptors Proteins 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 206010048627 thoracic outlet syndrome Diseases 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- 229940100640 transdermal system Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000036722 ulnar neuropathy Diseases 0.000 description 1
- 230000004855 vascular circulation Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36021—External stimulators, e.g. with patch electrodes for treatment of pain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0484—Garment electrodes worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36034—Control systems specified by the stimulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/3615—Intensity
- A61N1/36153—Voltage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/3615—Intensity
- A61N1/36157—Current
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36167—Timing, e.g. stimulation onset
- A61N1/36171—Frequency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36167—Timing, e.g. stimulation onset
- A61N1/36175—Pulse width or duty cycle
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662439283P | 2016-12-27 | 2016-12-27 | |
| US62/439,283 | 2016-12-27 | ||
| PCT/US2017/065243 WO2018125538A1 (en) | 2016-12-27 | 2017-12-08 | Article for treating diabetic peripheral neuropathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20190100205A true KR20190100205A (ko) | 2019-08-28 |
Family
ID=60888650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020197018171A Withdrawn KR20190100205A (ko) | 2016-12-27 | 2017-12-08 | 당뇨성 말초 신경병증 치료용 물품 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11471677B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3562541B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2020503111A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20190100205A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017387791B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2019007714A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018125538A1 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023191236A1 (ko) * | 2022-03-30 | 2023-10-05 | (주)웨이브트리 | 손 또는 발 부위의 말초신경 자극장치 |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9833614B1 (en) | 2012-06-22 | 2017-12-05 | Nevro Corp. | Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods |
| CN105142714B (zh) | 2013-01-21 | 2018-02-16 | 卡拉健康公司 | 用于控制震颤的设备和方法 |
| US12453853B2 (en) | 2013-01-21 | 2025-10-28 | Cala Health, Inc. | Multi-modal stimulation for treating tremor |
| WO2015187712A1 (en) | 2014-06-02 | 2015-12-10 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor |
| EP4342516A3 (en) | 2015-06-10 | 2024-07-10 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor with detachable therapy and monitoring units |
| US10603482B2 (en) | 2015-09-23 | 2020-03-31 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation in the finger or hand to treat hand tremors |
| CN108778411B (zh) | 2016-01-21 | 2022-06-03 | 卡拉健康公司 | 用来治疗与膀胱过动症相关的疾病的用于外周神经调制的系统、方法和装置 |
| CN109803717B (zh) | 2016-08-25 | 2024-01-09 | 卡拉健康公司 | 通过周围神经刺激治疗心脏机能障碍的系统和方法 |
| US20180272132A1 (en) | 2017-01-19 | 2018-09-27 | Nevro Corp. | High frequency stimulation for treating sensory and/or motor deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods |
| CA3058786A1 (en) | 2017-04-03 | 2018-10-11 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder |
| EP3740274A4 (en) | 2018-01-17 | 2021-10-27 | Cala Health, Inc. | SYSTEMS AND METHODS FOR TREATING INFLAMMATORY INTESTINAL DISEASE USING PERIPHERAL NERVE STIMULATION |
| MX2024007971A (es) | 2018-12-07 | 2024-07-10 | Avent Inc | Dispositivo y metodo para modular selectiva y reversiblemente una estructura de sistema nervioso para inhibir dolor. |
| US12251560B1 (en) | 2019-08-13 | 2025-03-18 | Cala Health, Inc. | Connection quality determination for wearable neurostimulation systems |
| US11890468B1 (en) | 2019-10-03 | 2024-02-06 | Cala Health, Inc. | Neurostimulation systems with event pattern detection and classification |
| US20210121682A1 (en) * | 2019-10-27 | 2021-04-29 | Texas Woman's University | Sock that wirelessly delivers electrical signals directly to the foot and ankle muscles for the treatment of pain |
| US11878167B2 (en) | 2020-05-04 | 2024-01-23 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| BR112022022112A2 (pt) | 2020-05-04 | 2022-12-13 | Btl Healthcare Technologies As | Dispositivo para tratamento não assistido do paciente |
| US12350490B2 (en) * | 2022-05-04 | 2025-07-08 | Neurological Fitness Equipment and Education LLC | Electrotherapy glove for delivery of amplitude modulated pulsed direct current during manual therapy treatment |
| GB2619011A (en) * | 2022-05-19 | 2023-11-29 | Guys And St Thomas Nhs Found Trust | Apparatus and method for causing vasoconstriction by electrical stimulation |
| US11986657B2 (en) | 2022-07-01 | 2024-05-21 | Nevro Corp. | Neurostimulation for treating sensory deficits, and associated systems and methods |
| AU2023201838B2 (en) * | 2023-03-24 | 2024-11-21 | Taiwan Resonant Waves Research Corp. | Electrical stimulation system and a method thereof |
| US12491363B2 (en) | 2023-03-24 | 2025-12-09 | Taiwan Resonant Waves Research Corp. | Electrical stimulation system and a method thereof |
| WO2024233824A1 (en) * | 2023-05-09 | 2024-11-14 | Nevro Corp. | Long pulse width spinal cord stimulation for treating diabetic neuropathy, and associated systems and methods |
| US20250018173A1 (en) * | 2023-07-10 | 2025-01-16 | Steve O'neal | Sensory Control System |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4521365A (en) | 1983-12-20 | 1985-06-04 | Bio Research Inc. | Glove molding apparatus and method |
| US5693401A (en) | 1996-05-01 | 1997-12-02 | Kimberly-Clark Worldwide, Inc. | Surgical glove retainer |
| US7013179B2 (en) * | 2000-01-07 | 2006-03-14 | Biowave Corporation | Percutaneous electrode array |
| MXPA03011015A (es) | 2001-06-01 | 2004-03-19 | I Flow Corp | Dispositivo y metodo de bolo de grande volumen. |
| US20040039417A1 (en) | 2002-04-16 | 2004-02-26 | Medtronic, Inc. | Electrical stimulation and thrombolytic therapy |
| US6745078B1 (en) * | 2002-04-24 | 2004-06-01 | Kelly W. Buchner | Procedure and machine for electro-inducing/stimulating deep-layered muscle contractions using a biphasic faradic pulse sequence |
| PT1608303T (pt) * | 2003-03-06 | 2018-07-09 | Univ Boston | Aparelho para melhoramento do equilíbrio e da marcha de seres humanos e prevenção de lesões do pé |
| CA2876835C (en) * | 2003-06-24 | 2020-06-30 | Medrelief Inc. | Apparatus and method for bioelectric stimulation, healing acceleration, pain relief, or pathogen devitalization |
| JP4057558B2 (ja) * | 2004-06-09 | 2008-03-05 | 伊藤超短波株式会社 | 筋肉トレーニング装置 |
| EP2517755B1 (en) * | 2004-10-05 | 2022-08-31 | Medtronic Ardian Luxembourg S.à.r.l. | Apparatus for renal neuromodulation |
| US7542804B2 (en) * | 2004-12-03 | 2009-06-02 | Alfred E. Mann Foundation For Scientific Research | Neuromuscular stimulation to avoid pulmonary embolisms |
| US9339641B2 (en) * | 2006-01-17 | 2016-05-17 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
| WO2007088547A2 (en) * | 2006-02-02 | 2007-08-09 | Tylerton International Inc. | Metabolic sink |
| WO2007092330A1 (en) * | 2006-02-03 | 2007-08-16 | Synecor, Llc | Intravascular device for neuromodulation |
| EP2038004B1 (en) * | 2006-07-05 | 2018-01-24 | Precisis AG | System for treatment of neurological disorders via electrical stimulation |
| US20080195176A1 (en) | 2007-02-12 | 2008-08-14 | The Research Foundation Of State University Of New York | Raynaud's Conditions |
| CA2768835A1 (en) * | 2009-07-23 | 2011-01-27 | Emkinetics, Inc. | Method and apparatus for magnetic induction therapy |
| KR100994208B1 (ko) * | 2009-07-28 | 2010-11-12 | 이지훈 | 미세전류 자극용 양말 |
| CA2822755A1 (en) * | 2010-12-30 | 2012-07-05 | The Hospital For Sick Children | Methods and devices relating to non-invasive electrical nerve stimulation |
| US9271864B2 (en) * | 2011-10-04 | 2016-03-01 | Feinstein Patents Llc | Orthosis for range of motion, muscular and neurologic rehabilitation of the lower extremities |
| US10092750B2 (en) | 2011-11-11 | 2018-10-09 | Neuroenabling Technologies, Inc. | Transcutaneous neuromodulation system and methods of using same |
| US8958886B2 (en) * | 2012-12-31 | 2015-02-17 | Kimberly-Clark Worldwide, Inc. | Method and apparatus to increase tactile senstivity and proprioception in humans |
| JPWO2014136852A1 (ja) * | 2013-03-06 | 2017-02-16 | 学校法人 久留米大学 | 電気刺激装置 |
| WO2014164438A1 (en) * | 2013-03-11 | 2014-10-09 | Ohio State Innovation Foundation | Devices and systems for treating obstetric and gynecological disorders |
| EP2968910A4 (en) * | 2013-03-15 | 2016-11-02 | Emkinetics Inc | METHOD AND APPARATUS FOR TRANSDERMAL STIMULATION ON PALMARY AND PLANTAIRE SURFACES |
| GB2531619A (en) * | 2014-09-12 | 2016-04-27 | Innovarius Ltd | Apparatus and method for providing hyperthermia therapy |
| CN107106841B (zh) * | 2014-10-31 | 2021-06-25 | 阿文特公司 | 经由胫后神经刺激来监测和治疗病症的方法和系统 |
| US10092738B2 (en) | 2014-12-29 | 2018-10-09 | Ethicon Llc | Methods and devices for inhibiting nerves when activating brown adipose tissue |
| US10080884B2 (en) * | 2014-12-29 | 2018-09-25 | Ethicon Llc | Methods and devices for activating brown adipose tissue using electrical energy |
| US10583295B2 (en) * | 2015-12-22 | 2020-03-10 | Regents Of The University Of Minnesota | Systems and methods to provide sympathetic modulation therapy |
-
2017
- 2017-12-08 AU AU2017387791A patent/AU2017387791B2/en not_active Ceased
- 2017-12-08 US US16/469,182 patent/US11471677B2/en active Active
- 2017-12-08 MX MX2019007714A patent/MX2019007714A/es unknown
- 2017-12-08 KR KR1020197018171A patent/KR20190100205A/ko not_active Withdrawn
- 2017-12-08 EP EP17822881.3A patent/EP3562541B1/en active Active
- 2017-12-08 JP JP2019534277A patent/JP2020503111A/ja active Pending
- 2017-12-08 WO PCT/US2017/065243 patent/WO2018125538A1/en not_active Ceased
-
2022
- 2022-09-09 US US17/930,787 patent/US20230001202A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023191236A1 (ko) * | 2022-03-30 | 2023-10-05 | (주)웨이브트리 | 손 또는 발 부위의 말초신경 자극장치 |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2019007714A (es) | 2019-09-09 |
| EP3562541A1 (en) | 2019-11-06 |
| US20200023183A1 (en) | 2020-01-23 |
| US20230001202A1 (en) | 2023-01-05 |
| AU2017387791B2 (en) | 2022-04-28 |
| EP3562541B1 (en) | 2021-07-14 |
| JP2020503111A (ja) | 2020-01-30 |
| AU2017387791A1 (en) | 2019-06-13 |
| US11471677B2 (en) | 2022-10-18 |
| WO2018125538A1 (en) | 2018-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230001202A1 (en) | Article and method for treating diabetic peripheral neuropathy | |
| Lee et al. | Mechano-neuromodulation of autonomic pelvic nerve for underactive bladder: A triboelectric neurostimulator integrated with flexible neural clip interface | |
| AU2005205853B2 (en) | Method of routing electrical current to bodily tissues via implanted passive conductors | |
| JP5108787B2 (ja) | 埋め込まれた受動導体を介して電流を体組織へルーティングする方法 | |
| Collinger et al. | Neuroprosthetic technology for individuals with spinal cord injury | |
| US8560075B2 (en) | Apparatus and method for the treatment of headache | |
| AU2013368951B2 (en) | Method and apparatus to increase tactile sensitivity and proprioception in humans | |
| US20240325728A1 (en) | Electrodes for neuromodulation | |
| US20090326602A1 (en) | Treatment of indications using electrical stimulation | |
| Micera et al. | Wearable neural prostheses | |
| CN108136176A (zh) | 制造用于脊髓的经皮电刺激的电极阵列的方法 | |
| US20130253412A1 (en) | Roller-ball applicator for transdermal iontophoretic delivery | |
| KR20220077129A (ko) | 의료 치료 장치 | |
| Greig et al. | Electrical stimulation for wound healing: opportunities for E-textiles | |
| CN110404164A (zh) | 脊髓闭环性电刺激系统 | |
| KR101242553B1 (ko) | 전기침 플랫폼 | |
| EP4048372A1 (en) | Method and apparatus for controlling multi-site neurostimulation | |
| Torregrosa et al. | Bioelectric medicine and devices for the treatment of spinal cord injury | |
| Deshkar et al. | Unveiling Current Advances in Bioelectronic Medicine: A Comprehensive Review | |
| RAGNARSSON | The physiologic aspects and clinical application of functional electrical stimulation in rehabilitation | |
| Greig | E-textile based electrical stimulation for wound healing | |
| Bronzino et al. | History and Overview of Neural Engineering |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20190624 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination |